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Summary 
We have developed a generalized approach, using two 
hybrid interactions, to isolate Ha-Ras effector loop mu- 
tations that separate the ability of Ha-Ras to interact 
with different downstream effectors. These mutations 
attenuate or eliminate Ha-ras(G12V) transformation of 
mammalian cells, but retain complementary activity, 
as demonstrated by synergistic induction of foci of 
growth-transformed cells, and by the ability to activate 
different downstream components. The transforma- 
tion defect of Ha-ras(G12V, E37G) is rescued by a mu- 
tant, rafl, that restores interaction. These results indi- 
cate that multiple cellular components, including Rafl, 
are activated by Ha-Ras and contribute to Ha-Ras- 
induced mammalian cell transformation. 
Introduction 
Ras is an essential component in the transduction of extra- 
cellular signals that induce proliferation and differentia- 
tion. It is a membrane-localized guanine nucleotide-bind- 
ing protein that is active in the GTP-bound state. Activating 
mutations in Ras result in constitutive signaling to down- 
stream elements and are found at a high frequency in a 
wide variety of tumors (Barbacid, 1987; Bollag and McCor- 
mick, 1991). The serine/threonine kinase Raf is a leading 
candidate for a downstream target of Ras. Mammalian 
ras is a proto-oncogene (Bonner et al., 1986), and the 
activated form induces cellular esponses similar to those 
of activated Ras (Morrison, 1990). Raf acts downstream 
of Ras, at least in some cell types, as inferred bythe ability 
of activated Raf to bypass dominant interfering ras mu- 
tants or anti-Ras antibodies (Smith et al., 1986; Cai et al., 
1990), and by the ability of dominant-negative mutants of 
Raf to interfere with Ras signaling (Kolch et al., 1991). 
Furthermore, Ras and Raf can be coimmunoprecipitated 
from activated mammalian cells (Finney et al., 1993; Koide 
et al., 1993; Hallberg et al., 1994), and immobilized purified 
GTP-bound Ras can bind Raf from cell extracts (Moodie et 
al., 1993). A Ras-Raf interaction is also observed between 
Saccharomyces cerevisiae-expressed fusion proteins in 
the yeast two-hybrid system (Van Aelst et al., 1993; Vojtek 
et al., 1993), and purified Ras can bind a purified truncated 
form of Raf in vitro (Warne and Viciana, 1993; Zhang et al., 
1993). Raf activates the serine/threonine protein kinase 
MAPK (for mitogen-activated protein kinase) through an 
activation of MEK (for MAPK or extracellular signal-regu- 
lated kinase [ERK] kinase) (Dent et al., 1992; Howe et al., 
1992; Kyriakis et al., 1992; Macdonald et al., 1993). These 
kinases are believed to convey growth and differentiation 
signals to the nucleus, resulting in the induction of appro- 
priate gene expression (Hill et al., 1993; Marais et al., 
1993; Cowley et al., 1994). These results have led to a 
linear model of Ras signaling in which Ras activation leads 
to the sequential activation of Raf, MEK, and MAPK. 
Ras is conserved in every eukaryote examined thus far 
(reviewed by Bollag and McCormick, 1991). All known ras 
genes encode an identical stretch of nine amino acids in 
the amino-terminal half (amino acids 32-40 in Ha-Ras) 
that undergoes a major conformational shift when Ras 
binds GTP. Certain mutations in this region eliminate the 
ability of Ras to bind and activate known downstream com- 
ponents without affecting binding and hydrolysis of GTP. 
For these reasons, this region of Ras has been termed 
the effector loop (reviewed by Polakis and McCormick, 
1993). Despite a conserved effector loop, several different 
downstream targets have been identified that interact with 
Ras in diverse cell types. These include Raf, S. cerevisiae 
adenylyl cyclase (CYR1) (Vojtek et al., 1993), and the puta- 
tive serine/threonine protein kinase byr2 in Schizosac- 
charomyces pombe (Van Aelst et al., 1993). S. cerevisiae 
CYR1 is necessary for the regulation of cell growth and 
is activated by RAS in vitro (Wigler et al., 1988). S. pombe 
byr2 is required for pheromone-induced sexual differentia- 
tion (Wang et al., 1991). It acts downstream of ras (Wang 
et al., 1991) and binds ras in the two-hybrid system (Van 
Aelst et al., 1993). Byr2 has structural homology to mam- 
malian MEK kinase (MEKK) in its catalytic domain (Lange- 
Carter et al., 1993). Other proteins that interact with the 
effector loop of Ras are the GAP/NF-1 family of GTPase- 
activating proteins (reviewed by Bollag and McCormick, 
1991), the scdl protein of S. pombe (Chang et al., 1994), 
and phosphatidylinositol-3-OH kinase (PI(3)K) (Rodriguez- 
Viciana et al., 1994). Aside from the kinase domains of 
Rafl and byr2, which are not required for interaction with 
RAS, there is no known homology among the Ras effector 
loop-binding proteins. 
Ras not only interacts with diverse targets in evolution- 
arily divergent organisms, it also interacts with diverse 
targets within the same cell. Genetic evidence from both 
S. pombe and S. cerevisiae indicates the existence of mul- 
tiple Ras effectors in each organism (Wigler et al., 1988; 
Wang et al., 1991; Chang et al., 1994). There is also evi- 
dence of multiple Ras targets in vertebrate systems. Acti- 
vated Ras induces the expression in PC12 cells of certain 
neurite-specific genes that are not induced by activated 
Raf (D'Arcangelo and Halegoua, 1993), possibly through 
the activation of MEK by a mechanism independent of 
Raf (Lange-Carter and Johnson, 1994; Lange-Carter et 
al., 1993; Minden et al., 1994a). In 3T3 L1 cells, oncogenic 
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Figure 1. E37G and T35S Mutations Separate the Ability of Ha-Ras 
to Interact with Targets in the Yeast Two-Hybrid Assay 
I~-Galactosidase activity was determined by filter assay. Ha-ras mu- 
tants were expressed as LexA-binding domain (LBD) fusions, and tar- 
gets were expressed as GAD fusions (RAF, byr2) or VP16-activating 
domain (VAD) fusions (CYR1, CDC25) in the yeast reporter strain L40 
(Vojtek et al., 1993). Yeast patches containing interacting protein pairs 
are dark, owing to ~-galactosidase activity producing an X-Gal cleav- 
age product. Yeast patches containing noninteracting protein pairs 
remain white, owing to the absence of detectable 13-galactosidase ac- 
tivity. 
ras activated MAPK, but oncogenic raf did not (Porras et 
al., 1994). Ha-Ras is required for multiple signals induced 
by v-Src in fibroblasts, some of which may be independent 
of Raf (Qureshi et al., 1992), and the induction of human 
T cell receptor [(3 gene expression by v-Raf is blocked by 
a dominant interfering ras mutant (Wotton et al., 1993). 
In this report, we have explored whether Ha-Ras can 
transform mammalian cells via multiple interactions. We 
have used the yeast two-hybrid assay developed by Fields 
and Song (1989) to isolate Ha-ras mutants defective in 
their effector interactions and have assayed their function 
in yeast and mammalian cells, 
Results 
Ha-ras(T35S) and Ha-ras(E37G) Have 
Complementary Two-Hybrid Interactions 
We used the yeast two-hybrid protein interaction detection 
system (Fields and Song, 1989) to identify mutations in 
Ha-Ras that separate its ability to interact with Rafl from 
its ability to interact with byr2. Ha-ras was randomly muta- 
genized along its entire length by polymerase chain reac- 
tion (PCR), taking advantage of the inherent nucleotide 
misincorporation frequency of Taq polymerase as de- 
scribed by Zhou et al. (1991). A library of mutated Ha-ras 
genes was ~used to the GAL4 DNA-binding domain (GBD). 
This library was separately screened with both a byr2- 
GAD (for GAL4-activating domain) fusion and a Rafl-GAD 
fusion to identify clones that failed to interact with these 
targets in the yeast two-hybrid reporter strain YPB2. In 
this fashion, 150 Ha-ras clones that failed to interact with 
byr2 and 150 Ha-ras clones that failed to interact with Rafl 
were isolated. Clones that failed to interact with byr2 were 
in turn screened for those that still interacted with Rafl; 
and clones that failed to interact with Rafl were screened 
for those that still interacted with byr2. Among these, Ha- 
ras mutations that passed the second round of screening 
were isolated and sequenced. One of these, Ha-ras 
(T35S), contains a conservative substitution of serine for 
threonine at position 35 and was found to interact with 
Rafl but not byr2, Another, Ha-ras(E37G), contains a sin- 
gle amino acid substitution of glutamic acid for glycine at 
position 37, which disrupts the interaction of Ha-Ras with 
Table 1. Two-Hybrid Interactions between Ha-ras Mutants and 
Ha-Ras Targets 
Mutant STE11 Rafl byr2 CYR1 CDC25 raf1(S257L) 
STE11 + - - 
Ha-Ras + + + + + 
Ha-ras(G 12V) + + + + + 
Ha-ras(E37G) - - + + - + 
Ha-ras(G12V, E37G) - - + + - + 
Ha-ras(T35S) - + + + 
Ha-ras(G12V, T35S) - + + + 
Ha-ras(G 15A) - + - 
Ha-ras(T35A) - + - 
Ha-ras alleles and STE11 were expressed as LBD fusions. Ha-Ras 
targets were expressed as GAD or VAD fusions (see Figure 1). Pairs 
were coexpressed in the yeast reporter strain L40. STE11 is an S. 
cerevisiae kinase that interacts with itself. Plus represents apositive 
indication of ~-galactosidase activity using filter assays. At least four 
independent transformants were tested for each pair. 
Rafl but not with byr2. Ha-ras(T35S) and Ha-ras(E37G) 
were also tested for the ability to interact with the S. cere- 
visiae RAS effector CYR1 (for adenylyl cyclase) and the 
S. cerevisiae RAS GDP/GTP exchange factor CDC25. 
Both of these proteins have previously been shown to inter- 
act with Ha-Ras in the two-hybrid system (Vojtek et al., 1993). 
Ha-ras(T35S) retains the ability to interact with CDC25, 
but is defective in CYR1 interaction. Ha-ras(E37G) retains 
the ability to interact with CYR1, but is defective in CDC25 
binding (Figure 1, Table 1). Both Ha-ras mutants are within 
the effector loop. The E37G mutation is to our knowledge 
the first effector loop mutation shown to have an effect on 
physical interaction with a GDP/GTP exchange factor. 
In Yeast, Activity of Ha-ras(T35S) and Ha-ras(E37G) 
Is Consistent with Effector Interactions 
The ability of Ha-ras(T35S) and Ha-ras(E37G) to interact 
with byr2 in vivo was tested by expression in ras l  "~' S. 
pombe haploid and diploid strains. S. pombe ras l  is re- 
quired for sexual differentiation and normal cell shape 
(Nadin-Davis et al., 1986). A ras l  "lj strain is defective in 
conjugation and sporulation and has a rounded morphol- 
ogy rather than the elongated morphology of wild-type 
cells. Byr2 acts immediately downstream of rasl, and 
overexpression of byr2 rescues the sporulation defect but 
not the conjugation or morphology defect of ras l  "uH cells 
(Wang et al., 1991). Ha-Ras fully substitutes for rasl, in- 
cluding induction of wild-type levels of sporulation in a 
ras ln ' l ras l  ~"~ diploid (Nadin-Davis et al., 1986). Ha- 
ras(T35S) was defective in the ability to induce sporulation, 
possibly owing to a defect in interaction with byr2. Ha- 
ras(E37G) induced wild-type levels of sporulation in 
ras l " " l ras l  " '  cells, but cell shape remained aberrant (Fig- 
ure 2A). Conjugation was not rescued in haploid ras l  "u" S. 
pombe expressing either Ha-ras(E37G) or Ha-ras(T35S) 
(data not shown). 
Ha-ras(T35S) and Ha-ras(E37G) were also tested for 
function in S. cerevisiae. An S. cerevisiae ras l  "u', ras2 t~ 
strain cannot grow at 37°C, presumably because of re- 
duced CYR1 activity (Powers et al., 1989). Wild-type Ha- 
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Figure 2. Complementation of rasl  ""~ Defects in S. pombe and rasl  "~ 
rasE ~ in S. cerevisiae 
(A) Ha-Ras and Ha-ras mutants, under control of the S. pombe adhl  
promoter, were expressed in the rasl"u"lrasl "u' diploid SPRN1D. (a), 
vector alone; (b), Ha-ras; (c), Ha-ras(E37G); (d), Ha-ras(T35S). 
(B) Ha-Ras and Ha-ras mutants, under control of the S. cerevisiae 
ADH1 promoter, were expressed in the S. cerevisiae ras l " "  ras'Z' 
strain STS8. Three independent transformants were analyzed. 
Ras can activate CYR1 (Kataoka et al., 1985) and rescues 
this temperature sensitivity. H a-ras(T35S) does not restore 
growth at 37°C, reflecting its inability to interact with 
CYR1. On the other hand, Ha-ras(E37G) fully restores the 
temperature-sensitive growth of the ras l " " ,  ras2  t~ strain. 
The results of in vivo function are thus consistent with the 
two-hybrid results. 
Ha-ras(G12V, T35S)and Ha-ras(G12V, E37G) Have 
Complementary Transforming Activity 
in Mammalian Cells 
To explore the activity of the mutant Ha-ras proteins in 
mammalian cells, the activating mutation, G12V, was in- 
troduced in each. Ha-ras(G12V, T35S) and Ha-ras(G12V, 
E37G) have the same profile of two-hybrid interactions 
as those observed with Ha-ras(T35S) and Ha-ras(E37G), 
respectively (Table 1). Ha-ras(G12V, T35S)and Ha-ras 
(G12V, E37G), under control of the cytomegalovirus 
(CMV) promoter, were transfected into NIH 3T3 and RAT4 
cells. Ha-ras(G12V, E37G) was completely defective in 
focus formation, displaying levels of activity >300-fold 
lower than Ha-ras(G 12V). Ha-ras(G12V, T35S) was atten- 
NIH 3T3 HeLa 
cn 
== ~ = = 
:c 
Figure 3. Activation of SRE-Dependent CAT Expression by Ha-rae 
Mutants 
(a) The indicated pDCR-Ha-Ras plasmids were transfected inNIH 3T3 
cells at 3 pg/transfection. Empty vector (6 p.g) was used as the negative 
control. Cell extract volumes used in CAT assays were normalized 
to expression of a cotransfected ~-galactosidase reporter plasmid, 
pCH110. 
(b) The indicated pDCR-Ha-Ras plasmids or empty vector were trans- 
fected in HeLa cells at 5 pg per transfection. Extract volumes used 
were normalized as in (a). All experiments were repeated at least wice 
with similar results. 
uated in the ability to induce foci, producing approxi- 
mately 20-fold fewer foci per microgram of DNA than Ha- 
ras(G12V) (Table 2). When Ha-ras(G12V, E37G) and 
Ha-ras(G12V, T35S) were cotransfected, there was an 
8- to 10-fold increase in focus formation above the level 
observed with Ha-ras(G12V, T35S) alone (Table 2). This 
result suggests that Ras-induced transformation requires 
at least two separate Ras activities, each mutant providing 
a complementary activity, resulting in a strong transforma- 
tion signal. 
Ha-ras(G12V, E37G) and Ha-ras(G12V, T35S) Have 
Different Profiles of Activation in Vertebrate Cells 
Induction of serum response lement (SRE)-dependent 
transcription is a consequence of Ras and Raf activation 
(Yarnauchi et al., 1993; Hipskind et al., 1994). We mea- 
sured the ability of Ha-ras(G 12V, E37G) and Ha-ras(G12V, 
T35S) to induce SRE-dependent ranscription during tran- 
sient expression in NIH 3T3 cells by using a chlorarnpheni- 
col acetyltransferase (CAT) reporter construct under 
control of a 5X-SRE promoter (Lee and Gilman, 1994). 
Ha-ras(G12V, E37G) did not induce expression of the CAT 
reporter, which was highly induced by Ha-ras(G12V). Ha- 
ras(G12V, T35S) retains the ability to induce this reporter, 
although to a lesser extent than that observed with Ha- 
ras(G12V). Cotransfection of Ha-ras(G12V, T35S) and Ha- 
ras(G12V, E37G) did not induce expression of the CAT 
reporter above the level observed with Ha-ras(G12V, 
T35S) alone (Figure 3a). Therefore, these mutants do not 
act cooperatively on this pathway. 
Another class of ser ine l th reon ine  protein kinases that 
is responsive to activated Ras in mammalian cells consists 
of the c-Jun N-terminal kinases (JNKs) (Hibi et al., 1993; 
Ha-Ras Mutations Define Multiple Ha-Ras Functions 
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Table 3. JNK and ERK Activation in HeLa Cells 
Ha-Ras Variant J NK ERK 
Ha-ras(G 12V) 100 100 
Ha-ras(G12V, E37G) 60 +- 8 32 __ 3 
Ha-ras(G12V, T35S) 70 _+ 11 84 _+ 12 
Control 19 _4- 5 3 _+ 1 
Ha-ras mutants were expressed in HeLa cells in the vector pSRm 
Control is HeLa cells with the vector alone. JNK and ERK activity 
induced by Ha-ras(G12V) was set at 100. Activities induced by the 
mutants and control were normalized to Ha-ras(G12V). Values are 
expressed as the average of two independent experiments. 
CONTROL HRAS (G12V) HRAS (G12V,T35S) HRAS (G12V,E37G) 
hr 10 1 2 4u0  1 2 3 4]10 1 2 3 4110 1 2 3 4 J 
Figure 4. Activation of p42 MAPK in Xenopus Oocyte Extracts 
Extracts were incubated for the indicated times with 150 i~g/ml purified 
recombinant His6-Ha-Ras proteins attached to ProBond resin (In- 
vitrogen Corporation). The control extract was incubated in buffer with 
ProBond resin alone. The phosphorylated (activated) form of p42 
MAPK migrates with a slower mobility on polyacryiamide g ls and is 
indicated by the arrow. 
Derijard et al., 1994). We examined the ability of Ha- 
ras(G 12V, E37G) and H a-ras(G 12V, T35S) to activate J N K 
in HeLa cells as assayed by c-Jun phosphorylation by anti- 
JNK1 immune complexes (Minden et al., 1994b). In con- 
trast with SRE induction, the E37G mutation does not dis- 
rupt JNK1 activation by activated Ha-Ras (Table 3). 
Ha-ras(G12V, T35S) also retains the ability to activate JNK. 
We compared JNK activation by the mutant Ha-ras pro- 
teins with their ability to activate extracellu lar signal-regu- 
lated kinase 2 (ERK2), a MAPK downstream of Raf (Dent 
et al., 1992; Kyriakis et al., 1992), as assayed by phosphor- 
ylation of myelin basic protein (MBP) by anti-ERK2 im- 
mune complexes from HeLa cells. Ha-ras(G12V, E37G) 
reproducibly activated MBP kinase activity in the ERK2 
immune complex. However, the level of activation was 
lower than that observed with Ha-ras(G12V) and Ha- 
ras(G12V, T35S) (Table 3). Interestingly, while both Ha- 
ras(G12V) and Ha-ras(G12V, T35S) induced SRE-depen- 
dent transcription in HeLa cells, Ha-ras(G12V, E37G) did 
not (Figure 3b), suggesting either that ERK2 activation by 
Ha-ras(G12V, E37G) was too weak to induce this re- 
sponse, or that it does not mediate the response. 
Xenopus p42 MAPK is responsive to activated Ha-Ras 
in cell-free oocyte extracts (Shibuya et al., 1992). A compo- 
nent present in oocytes called REKS (for Ras-dependent 
ERK/MAP kinase stimulator) has been identified that acti- 
vates a MAPK through a MEK in an activated Ras- 
dependent manner (Itoh et al., 1993). We examined the 
ability of the Ha-ras mutants to activate p42 MAPK in Xeno- 
pus oocyte extracts by use of purified recombinant oligo- 
histidine (His6)-tagged Ha-Ras proteins. In contrast with 
the results obtained in HeLa and NIH 3T3 cells, Ha- 
ras(G12V, E37G) is a strong activator of this kinase, 
whereas Ha-ras(G12V, T35S) has a detectable but attenu- 
ated activity (Figure 4). 
Complementation of Ha-ras(G12V, E37G) 
by an Interacting Mutant, rafl 
The Ha-ras(G12V, E37G) transformation defect may be 
due to its inability to interact with Rafl. To test this, we 
used the two-hybrid assay to identify Rafl mutations that 
suppress the Raft-binding defect of Ha-ras(E37G). The 
N-terminal half of Rafl interacts with Ras, while the C-ter- 
minal half contains the catalytic domain that interacts with 
MEK (Van Aelst et al., 1993; Vojtek et al., 1993). A library 
of mutations in the N-terminal half of Rafl (amino acids 
1-281) was created by PCR using the same protocol used 
to create the mutated Ha-ras library. This library was fused 
to the wild-type C-terminal half of Rafl in pGADGH to pro- 
duce full-length genes fused to GAD. The Ha-ras(E37G)- 
GBD fusion was used to screen this library for mutated 
Rafl proteins that had acquired the ability to interact with 
the mutant Ha-ras. To ensure that full-length rafl proteins 
were expressed, clones that interacted with Ha-ras(E37G) 
were further tested for their ability to interact with MEK. 
Three different rafl mutations were isolated that inter- 
acted with Ha-ras(E37G) and retained the ability to interact 
with MEK. All three mutations were located in conserved 
region 2 (CR2), the second of the three regions highly 
conserved among all Raf homologs (Morrison, 1990). CR2 
is 20 amino acids in length and is rich in serine and threo- 
nine residues. The mutations found were single amino 
acid substitutions consisting of a change from arginine to 
glycine at position 256, from serine to leucine at position 
257, and from serine to proline at the same position. These 
mutations did not diminish interaction with wild-type Ha- 
Ras or Ha-ras(G12V), or restore interaction with Ha- 
ras(G 15A) or H a-ras(T35A), mutations previously found to 
disrupt Rafl interaction (Van Aelst et al., 1993; Vojtek et 
al., 1993) (see Table 1). 
Raf1(S257L), under control of a CMV promoter, was 
tested for its capacity to restore transformation potential 
to Ha-ras(G12V, E37G). NIH 3T3 and RAT4 cells were 
transfected with wild-type Ha-Ras, Ha-ras(G12V), Ha- 
ras(G12V, E37G), Rafl, and raf1(S257L), alone or in com- 
bination. The results are summarized in Table 2. As noted 
above, Ha-ras(G12V, E37G) does not induce foci. Both 
wild-type Rafl and raf1(S257L) also failed to induce foci. 
Wild-type Ha-Ras weakly induces foci in NIH 3T3 cells. 
This induction is slightly increased by cotransfection with 
wild-type Rafl, as has been previously reported (Cua- 
d rado et ai., 1993). Ras(G 12V) is a potent inducer of focus 
formation, but also cooperates with wild-type Rafl. 
Raf1(S257L) does not cooperate with either Ha-Ras or 
Ha-ras(G 12V) and appears to be interfering when cotrans- 
fected with Ha-ras(G12V) in NIH 3T3 cells. The trans- 
forming potential of Ha-ras(G12V, E37G) is partly rescued 
by cotransfection with wild-type Rafl in both cell types. 
Cotransfection with raf1(S257L), however, results in a 
>30-fold increase in focus formation in NIH 3T3 cells and 
a >10-fold increase in focus formation in RAT4 cells above 
the level observed with a cotransfection of Ha-ras(G12V, 
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Figure 5. Ha-ras(G12V, E37G) and raf1(S257L) Synergize to Induce 
SRE-Dependent CAT Expression 
NIH 3T3 cells were transfected with 5 I~g of pCEP4-Rafl (gray bars) 
or pCEP4-raf1(S257L) (black bars) along with the indicated concentra- 
tion of pDCR-Ha-ras(G12V, E37G). CAT activity is expressed as the 
fold induction over the basal evel (set at 1) observed with Rafl alone 
or raf1(S257L) alone. In repeated experiments, basal CAT activity in- 
duced by rafl ($257L) was similar to or less than that induced by Rafl. 
pDCR-Ha-ras(G12V, E37G) was transfected alone at the highest con- 
centration used in the cotransfections (30 ~g) and did not induce CAT 
activity above the level observed with empty vector. These experi- 
ments were repeated twice with similar results. 
E37G) and wild-type Rafl. Similar results were obtained 
with the other two rafl mutants (data not shown). 
The ability of Ha-ras(G12V, E37G) to induce SRE- 
dependent transcription when coexpressed with Rafl or 
rafl ($257L) was also examined. A constant concentration 
of Rafl or raf1(S257L) DNA was transfected into NIH 3T3 
cells with increasing concentrations of DNA encoding Ha- 
ras (G12V, E37G). Both Rafl and raf1(S257L)induce x- 
pression of the SRE-CAT reporter when transfected 
alone. The level of raf1(S257L) induction is similar to or 
less than the level of Rafl induction (data not shown). 
Cotransfection of Ha-ras(G12V, E37G) with raf1(S257L) 
resulted in increased levels of SRE induction relative to 
raf1(S257L) alone, whereas cotransfection of Ha-ras 
(G12V, E37G) with wild-type Rafl resulted in decreased 
levels of SRE induction relative to Rafl alone (Figure 5). 
Discussion 
We have used the yeast two-hybrid system to identify com- 
plementary Ha-ras mutants that have different down- 
stream activities in mammalian cells. Again using the two- 
hybrid system, we have identified mutations in Ha-Ras 
and Rafl that were used to demonstrate that interaction 
between these proteins can mediate transformation of 
mammalian cells. The approaches we have taken can be 
used more generally to dissect the roles played by proteins 
that have multiple functions and to evaluate the biological 
significance of the interaction between two proteins. 
Ha-ras Effector Loop Mutants That Distinguish 
Downstream Targets Have Altered 
Profiles of Activity 
Ha-ras(T35S) and Ha-ras(E37G) contain mutations that 
were selected by using the two-hybrid system to separate 
the ability of Ha-Ras to interact with known downstream 
targets. These mutations both map to the effector loop, 
yet the profiles of activity of Ha-Ras proteins containing 
these mutations differ greatly. While yeasts are responsive 
to wild-type Ha-Ras, the T35S mutant is inactive in both 
S. cerevisiae and S. pombe, whereas the E37G mutant 
retains some Ras functions in both yeasts. Ha-ras(G12V) 
is a strong activator of p42 MAPK in Xenopus oocytes, a 
response that is probably mediated by a protein kinase 
called REKS (Itoh et al., 1993). The Ha-ras(G12V, E37G) 
fully retains this activity, whereas Ha-ras(G12V, T35S) ap- 
pears significantly attenuated. In contrast with the results 
with yeasts and Xenopus oocytes, Ha-ras(G12V, E37G) 
is completely defective in focus formation in NIH 3T3 and 
RAT4 cells, while Ha-ras(G 12V, T35S) retains partial activ- 
ity. Consonant with this, in transient expression studies, 
the former does not induce SRE-dependent transcription 
of a reporter gene in NIH 3T3 or HeLa cells, while the 
latter does. We also examined the ability of these mutants 
to activate ERK2 and JNK1 protein kinases in transient 
expression studies. While both mutants were able to acti- 
vate these kinases, Ha-ras(G 12V, E37G) was clearly atten- 
uated in ERK2 activation. This is consistent with the obser- 
vation that oncogenic ras  activates c-Jun and JNK via a 
separate pathway from the activation of ERK (Westwick 
et al., 1994; Minden et al., 1994a, 1994b). 
rafl Mutants That Restore Interaction with 
Ha-ras(E37G) in Yeast Restore Its Activity 
in Mammalian Cells 
We could detect absolutely no focus-forming activity of 
the Ha-ras(G 12V, E37G) mutant in either NIH 3T3 or RAT4 
cells. Since the Ha-ras(E37G) mutant was selected by its 
inability to interact with Rafl in the yeast two-hybrid sys- 
tem, this defect might be the result of the failure of the 
mutant to interact properly with Rafl in mammalian cells. 
In strong support of this idea, all three rafl mutants with 
which Ha-ras(G12V, E37G) can interact in the yeast two- 
hybrid system rescued focus formation by Ha-ras(G12V, 
E37G). These mutants are not activated forms of Rafl. 
First, they are unable to induce foci alone, and second, 
raf1(S257L) did not induce SRE-dependent expression 
above the level observed with wild-type Rafl. Further- 
more, the raf1(S257L) mutant did not cooperate with either 
Ha-ras(G12V) or wild-type Ha-Ras in focus induction. We 
found that Ha-ras(G12V, E37G) acted synergistically with 
raf1(S257L) but not with wild-type Rafl to induce an SRE 
reporter gene. These results constitute a formal genetic 
demonstration that one path by which Ha-Ras can act 
upon mammalian cells is through its physical interaction 
with Rafl. 
The three rafl mutants that can interact with Ha- 
ras(G12V, E37G) all have single mutations located in the 
CR2 of Rafl (Morrison, 1990). This implies that a common 
mechanism is at play to restore interaction. Previous stud- 
ies have not found a role for CR2 in binding Ha-Ras. Both 
two-hybrid interactions (Vojtek et al., 1993) and in vitro 
protein binding assays (Warne and Viciana, 1993; Zhang 
et al., 1993) indicate that the CR1 region of Rafl is suffi- 
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cient for interaction with Ha-Ras. In keeping with this, we 
have found that Ha-ras(E37G) retains the ability to bind 
a truncated form of Rafl that lacks the CR2 region (data 
not shown). Thus, the CR2 region might contribute a so- 
called proofreading function that ensures specificity in 
Rafl interactions. CR2 may block binding to Ha-ras 
(E37G), and the CR2 mutations may relieve this inhibition. 
More complex models are also possible. For example, 
R256G, $257L, and $257P may disrupt binding between 
the CR2 region of Rafl and a third protein, X, that is con- 
served between S. cerevisiae and mammals. The E37G 
mutation may prevent Ha-Ras from binding to a Raf l -X  
complex but not affect binding to Rafl alone. Possible 
candidate proteins for X are 14-3-3 proteins, which have 
been shown to bind CR2 of Rafl (Freed et al., 1994) and 
are conserved in S. cerevisiae (van Heusden et al., 1992). 
Such models predict the formation of nonproductive com- 
plexes between some normal cellular components and our 
mutant proteins. 
Multiple Ha-Ras Activities Can Contribute 
to Transformation 
Ha-ras(G12V, T35S) is severly irr~paired in its ability to 
induce foci in NIH 3T3 and RAT4 cells. This mutant still 
interacts with Rafl in yeast, retains the ability to induce 
SRE-dependent transcription, and can activate ERK2. Its 
interaction with Rafl in mammalian cells may neverthe- 
less be defective (Shirouzu et al., 1994), or it may also be 
defective in other respects. H a-ras(G 12V, E37G) is clearly 
defective in its interaction with Rafl and is incapable of 
focus induction yet retains an ability to enhance focus for- 
mation by Ha-ras(G12V, T35S) greatly. Thus, Ha-ras 
(G12V, E37G) supplies an activity that is lacking in Ha- 
ras(G12V, T35S). 
These observations suggest that Ha-Ras has at least 
two functions in mammalian cells, both of which can con- 
tribute to transformation, and which act synergistically. 
While it is conceivable that both mutants act solely upon 
Rafl ,  this seems unlikely to us. First, the synergy of the 
mutants in focus induction cannot be explained as a simple 
additive effect on Rafl ,  as the Ha-ras(G12V, E37G) mutant 
is completely defective for focus formation. Second, Ha- 
ras(G12V, E37G) does not cooperate with wild-type Rafl 
or Ha-ras(G12V, T35S)in SRE induction. To rule out Rafl 
formally as the sole target, however, would require moni- 
toring all its biological functions in stably transformed and 
cotransfected cells. 
High levels of activated Raf can transform mammalian 
cells (Morrison, 1990). This does not conflict with our con- 
clusion that Ha-Ras can activate at least one other path- 
way that contributes to transformation. In S. pombe, ras 
acts on at least two highly divergent pathways that con- 
verge upon sexual differentiation (Wang et al., 1991; 
Chang et al., 1994). In S. cerevisiae, RAS also acts on at 
least two effectors, one of which is cryptic and becomes 
apparent when the major effector pathway is blocked 
(Wigler et al., 1988). It is unclear whether activation of all 
the endogenous Rafl present in mammalian cells would 
be sufficient to account for full transformation by Ha- 
ras(G12V). 
We do not know all of the proteins that interact with 
Ha-Ras in mammalian cells and which of these still interact 
with Ha-ras(E37G). Among these may be another protein 
kinase, perhaps homologous to S. pombe byr2; Pl(3) ki- 
nase (Rodriguez-Viciana et al., 1994); and proteins in- 
volved in morphogenesis (Chang et al., 1994). We are 
currently using wild-type Ha-Ras and the Ha-Ras mutants 
to screen cDNA libraries for interacting proteins. Our ras 
mutants, and candidate effectors, and mutants derived 
from them, can facilitate dissection of the physiological 
roles of Ras in such processes as tumorigenicity, onco- 
gene cooperation, apoptosis, morphogenesis, and differ- 
entiation. 
Experimental Procedures 
Yeast Strains and Media 
The genotype of the S. cerevisiae reporter strain YPB2, used to test 
interactions between GBD and GAD fusions, is MATa ura3-52 his3- 
200 ade2-101/ys2-801 trp l-901/eu2-3,112 can" ga14-542 ga/80-538 
L YS2::GAL I,as-LEU2TATA-HIS3 URA3::GAL llT.mers~x~-CYCltat,-/acZ (pro- 
vided by P. Bartel and S. Fields). The genotype of L40, used to detect 
interactions between LBD and GAD or VAD fusions, is MATa trpl/eu2 
his3 LYS2::/exA-HIS3 URA3::/exA-/acZ (Vojtek et al., 1993). STS8 is 
MA Ta his3/eu2 ura3 trp l ade8 can1 ras l :URA3 ras2 ~ (Powers et al., 
1989). Strains were grown according to standard conditions in rich or 
synthetic media with appropriate supplements (Sherman et al., 1986) 
at 30°C, except for STS8, which was incubated at 25°C. 
The S. pombe strains SPRN (h 9°/eul-32 ade6-210 ura4-D18 rasl:: 
ura4) and SPR N D (h 9° leu 1-32 ade6-210 ura4-D 18 ras 1 : :ura4/ h90 leu 1 - 
32 ade6-210 ura4-D18 rasl::ura4) (Chang et al., 1994) were grown in 
rich or nutrient-limited synthetic media with the appropriate auxotro- 
phic supplements (Nadin-Davis et al., 1986). 
Library Construction and Screening 
Full-length human Ha-ras encoding a protein containing the C186S 
mutation was randomly mutagenized by PCR (Zhou et al., 1991) and 
ligated into the vector pHP5 (kindly provided by H.-P. Xu) to create 
in-frame fusions with the GAL4 DNA-binding domain (amino acids 
1-147). Screening for mutations that affected binding of Ha-Ras-G BD 
fusions to Rafl-GAD or byr2-GAD was performed in YPB2. Approxi- 
mately 3 x 10' transformants (selected on synthetic media lacking 
leucine and tryptophan) from each screen were assayed for J3-galacto- 
sidase activity on filters (Bartel and Fields, 1994). A mutant human 
rafl library was constructed as described for the mutant Ha-ras library, 
except that only nucleotides 1-843 were subjected to mutagenesis. 
These fragments were then ligated into pGADGH (described by Van 
Aelst et al., 1993) already containing wild-type rafl sequences from 
nucleotides 844-1946 to create full-length genes in-frame with the 
GAL4-activating domain. Screening for rafl mutations that interacted 
with Ha-ras(E37G)-GBD was performed in YPB2. 
Plasmids 
pHP5-Ha-ras(E37G) and pHP5-Ha-ras(T35S) were isolated from the 
mutant Ha-ras library and express Ha-Ras-GBD fusions, pHP5 is a 
variant of pGBT10 with a 4 bp insertion in the EcoRI site. pLexA-Ha- 
Ras, pLexA-Ha-ras(G12V), and pLexA-Ha-ras(G15A), which express 
Ha-Ras-LBD fusions, were provided by A. Vojtek (Vojtek et al., 1993). 
pBTM116-Ha-ras(E37G), pBTM116-Ha-ras(T35S), pBTM116-Ha-ras 
(T35A), pBTMl16-Ha-ras(G12V, E37G), and pBTMl16-Ha-ras (G12V, 
T35S) express Ha-Ras-LBD fusions. Full-length Ha-ras genes were in- 
serted as BamHI-Sall fragments into the BamHI-Sall site of pBTM116 
(Vojtek et al., 1993). pBTM116-STEll is described by Marcus et al. 
(1994). pVP16-CYR1 and pVP16-CDC25 were kindly provided by A. 
Vojtek (Vojtek et al., 1993). pGAD-Rafl, pGAD-byr2, and pGAD-STE11 
are as described (Van Aelst et al., 1993;-Marcus et al., 1994). pGAD- 
raf1(R256G), pGAD-rafl(S257L), and pGAD-rafl(S257P)express 
Rafl-GAD fusions and were isolated from the mutant rafl library. 
pAAU-Ha-Ras, pAAU-Ha-ras(E37G), and pAAU-Ha-ras(T35S) have 
BamHI fragments of full-length genes inserted into the BamHI site 
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of the S. pombe adhl expression vector pAAU (Wang et al., 1991). 
pAD4-Ha-Ras, pAD4-Ha-ras(E37G), and pAD4-Ha-ras(T35S) have 
SalI-Sacl fragments of full-length genes in the Sall-Sacl site of the 
S. cerevisiae ADH1 expression vector pAD4 (Ballester et al., 1989). 
pDCR is a mammalian expression vector containing the cytomegalovi- 
rus promoter followed by unique Sail and BamHI sites and the rabbit 
13-globin terminator and splice sequence. This region and the neo' gene 
under control of an SV40 promoter are flanked by Moloney murine 
leukemia retrovirus 5' and 3' long terminal repeats, pDCR-Ha-Ras and 
pDCR-Ha-ras(G12V) contain full-length Ha-ras inserted as SalI-Bglll 
fragments in the SalI-BamHI site of pDCR. pDCR-Ha-ras(G12V, 
E37G) and pDCR-Ha-ras(G12V, T35S) contain full-length genes in- 
serted as SalI-BamHI fragments in the SalI-BamHI site of pDCR. 
pCEP4-Rafl and pCEP4-raf1(S257L) contain full-length genes in- 
serted as XhoI-BamHI fragments in the XhoI-BamHI site of pCEP4 
(Invitrogen Corporation). pCEP4-Ha-ras(G12V, E37G) contains the 
full-length Ha-ras mutant inserted as a SalI-BamHI fragment in the 
XhoI-BamHI site of pCEP4, pSR~-Ha-ras(G12V), pSR~-Ha-ras(G12V, 
E37G), and pSR~-Ha-ras(G 12V, T35S) contain full-length genes under 
control of the SV40 promoter inserted as EcoRI-Pstl fragments in the 
EcoRI-Pstl site of pSR~ (Minden et al., 1994a). pTrcHisB-Ha- 
ras(G12V, E37G) and pTrcHisB-Ha-ras(G12V, T35S) contain full- 
length genes inserted as SalI-EcoRI fragments in the Sall-Xhol site 
of pTrcHisB (Invitrogen Corporation) to produce in-frame fusions with 
six histidine residues at the N-terminus. pTrcHis-Ha-ras(G12V) is as 
described (Shibuya et al., 1992). 
Mammalian Cell Transfections 
NIH 3T3 and RAT4 cells were transfected by the calcium phosphate 
precipitation method as described (Wigler et al., 1979). N IH 3T3 cells 
were passaged in Dulbecco's modified Eagle's medium (DMEM) (ICN 
Biomedicals, Incorporated) plus 10% calf serum (GIBCO BRL Life 
Technologies, Incorporated); 24 hr after transfection, cells were split 
into DMEM plus 5% calf serum for the focus assay and DMEM plus 
10% calf serum supplemented with 0.5 mg/ml G-418 sulfate (GIBCO 
BRL Life Technologies, Incorporated) to determine the transfection 
efficiency. Foci were scored under magnification after 14 days. RAT4 
cells were treated in an identical fashion, except that the focus assay 
was performed in DMEM plus 10% calf serum, and foci were scored 
under magnification after 21 days. 
CAT Assays 
NIH 3T3 or HeLa cells were transfected (Wigler et al., 1979) with 5X- 
SRE-CAT (Lee and Gilman, 1994), pCH110 (Pharmacia Biotech, Incor- 
porated), and tester plasmid(s). After transfection (12-16 hr), the cells 
were incubated in DMEM plus 0.5% calf serum for 24 hr. Cell extracts 
and CAT assays were performed as described (Sambrook etal., 1989). 
Transfection efficiencies were normalized by ~-galactosidase assays 
(Sambrook et al., 1989). CAT reactions were incubated for 2 hr at 37°C 
and separated on chromatography plates in one dimension. Reactions 
were visualized by autoradiography, or radioactivity was quantitated 
using an Ambios ~-scope plate reader. 
Protein Kinsse Assays 
HeLa cells were cotransfected with expression vectors encoding hem- 
agglutinin epitope-tagged ERK2 or JNK1 together with tester plas- 
mids. Protein kinase activity in cell extracts was measured by immune 
complex kinase assays using either MBP or glutathione S-transferase 
(GST)-cJun(1-79) as substrate as described previously (Minden et 
al., 1994a). Reactions were separated by SDS-polyacrylamide gel 
electrophoresis, and phosphorylation of substrates was quantitated 
by phosphorimager. 
Xenopus oocyte extracts were prepared as described (Shibuya et 
al., 1992). Expression and purification of HisrHa-Ras proteins was 
as described (Shibuya et al., 1992). Extracts were incubated with 150 
p,g/ml of protein for 0-4 hr. Reactions were separated on a polyacryl- 
amide gel, followed by Western blotting as described (Shibuya et al., 
1992). 
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